Cargando…

Screening Strategies for Hepatitis C Virus

Detalles Bibliográficos
Autores principales:	Lim, Aaron G., Trickey, Adam, Vickerman, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396359/ https://www.ncbi.nlm.nih.gov/pubmed/30859145 http://dx.doi.org/10.1002/hep4.1330

Ejemplares similares

Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination
por: Lim, Aaron G, et al.
Publicado: (2018)

Clustering of hepatitis C virus antibody positivity within households and communities in Punjab, India
por: Trickey, A., et al.
Publicado: (2019)

Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysis
por: Lim, Aaron G., et al.
Publicado: (2021)

The Effectiveness of Low Dead Space Syringes for Reducing the Risk of Hepatitis C Virus Acquisition Among People Who Inject Drugs: Findings From a National Survey in England, Wales, and Northern Ireland( )
por: Trickey, Adam, et al.
Publicado: (2022)

Hepatitis C virus-associated pruritus: Etiopathogenesis and therapeutic strategies
por: Alhmada, Youssef, et al.
Publicado: (2017)

Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review
por: Bivegete, Sandra, et al.
Publicado: (2023)

The burden of hepatitis C virus infection in Punjab, India: A population-based serosurvey
por: Sood, Ajit, et al.
Publicado: (2018)

Has resourcing of non‐governmental harm‐reduction organizations in Ukraine improved HIV prevention and treatment outcomes for people who inject drugs? Findings from multiple bio‐behavioural surveys
por: Trickey, Adam, et al.
Publicado: (2020)

Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling study
por: Trickey, Adam, et al.
Publicado: (2023)

Cost‐effectiveness of screening and treatment using direct‐acting antivirals for chronic Hepatitis C virus in a primary care setting in Karachi, Pakistan
por: Mafirakureva, Nyashadzaishe, et al.
Publicado: (2020)

The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial
por: Vold, Jørn Henrik, et al.
Publicado: (2023)

Elucidating Drivers for Variations in the Explosive Human Immunodeficiency Virus Epidemic Among People Who Inject Drugs in Pakistan
por: Lim, Aaron G, et al.
Publicado: (2021)

Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis
por: Oru, Ena, et al.
Publicado: (2021)

Optimization of hepatitis C virus screening strategies by birth cohort in Italy
por: Kondili, Loreta A., et al.
Publicado: (2020)

Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
por: Arum, Chiedozie, et al.
Publicado: (2021)

Hepatitis B and C Viruses and Hepatocellular Carcinoma
por: Bartosch, Birke
Publicado: (2010)

Extrahepatic manifestations in hepatitis C virus infection
por: Negro, Francesco, et al.
Publicado: (2017)

The Challenging Road to Hepatitis C Virus Eradication
por: Martínez, Isidoro, et al.
Publicado: (2021)

Risk factors of HIV and variation in access to clean needles among people who inject drugs in Pakistan
por: Capelastegui, Fernando, et al.
Publicado: (2023)

State of the Globe: Hepatitis C – Opportunistic versus Organized Screening
por: Raina, Sunil Kumar, et al.
Publicado: (2017)

Hepatitis C virus screening in Piemonte: an effective strategy to eliminate HCV chronic infections
por: Thomas, R, et al.
Publicado: (2023)

The Impact of Host Factors on Management of Hepatitis C Virus
por: Khattab, Mahmoud Aboelneen, et al.
Publicado: (2012)

Intravenous Drug Use and Hepatitis C Virus in Iran
por: Zobeiri, Mehdi, et al.
Publicado: (2012)

Hepatitis C Virus and Lichen Planus: The Real Association
por: Mahboobi, Nima, et al.
Publicado: (2010)

The hunt for a vaccine for hepatitis C virus continues
por: The Lancet Gastroenterology & Hepatology
Publicado: (2021)

Hepatocellular Carcinoma Risk, Outcomes, and Screening After Hepatitis C Eradication
por: D’Ambrosio, Roberta, et al.
Publicado: (2021)

Elimination of hepatitis C virus in Germany: modelling the cost-effectiveness of HCV screening strategies
por: Krauth, Christian, et al.
Publicado: (2019)

Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection
por: Kagawa, Tatehiro, et al.
Publicado: (2010)

Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure
por: Colpitts, Che C., et al.
Publicado: (2016)

Heterogeneity of Hepatitis C Virus Particles and Their Evolution During Infection
por: Budkowska, Agata
Publicado: (2017)

Treatment of people diagnosed with chronic hepatitis C virus infection
por: Bulterys, Marc, et al.
Publicado: (2018)

How to Optimize the Care Cascade of Hepatitis C Virus Infection
por: Kim, Beom Kyung
Publicado: (2022)

A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus
por: Fawsitt, Christopher G., et al.
Publicado: (2019)

Cost-effectiveness of Hepatitis C virus self-testing in four settings
por: Walker, Josephine G., et al.
Publicado: (2023)

Assessing the Effectiveness of Strategies in US Birth Cohort Screening for Hepatitis C Infection
por: Tsay, Cynthia J., et al.
Publicado: (2020)

Occult Hepatitis C Infection Should Be More Noticed With New Treatment Strategies
por: Rezaee Zavareh, Mohammad Saeid, et al.
Publicado: (2015)

Digging Deeper Into Hepatitis C Virus Outbreaks
por: Olmstead, Andrea D.
Publicado: (2016)

Impact and cost-effectiveness of non-governmental organizations on the HIV epidemic in Ukraine among men who have sex with men
por: Trickey, Adam, et al.
Publicado: (2022)

Awareness and Access to Therapy in Hepatitis C Virus Infected Patients, Key Barriers to Eliminate the Virus?
por: Kim, Do Young
Publicado: (2020)

Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus
por: Fawsitt, Christopher G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h70d5msuj564jb34r7i1242ier